The Editor's Roundtable: Intracoronary Hyperoxemic Therapy in Acute Myocardial Infarction

American Journal of Cardiology

Volumn 104, Issue 6, 2009, Pages 791-797

  Friedewald, Vincent E ^a   Gibbons, Raymond J ^b   O'Neill, William W ^c   Popma, Jeffrey J ^d   Stone, Gregg W ^e   Roberts, William C ^f  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HEART INFARCTION SIZE; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HEART VENTRICLE WALL MOTION; HUMAN; HYPEROXIA; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN THERAPY; PATIENT SELECTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SUPERSATURATION OXYGENATION THERAPY; TREATMENT CONTRAINDICATION;

EID: 69549156197     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.06.018     Document Type: Note

References (8)

1. Spears R.J., Wang B., Wu X., Prcevski P., Jiang A.J., Spanta A.D., Crilly R.J., and Brereton G.J. Aqueous oxygen: a highly O2-supersaturated infusate for regional correction of hypoxemia and production of hyperoxemia. Circulation 96 (1997) 4385-4391
2. O'Neill W.W., Martin J.L., Dixon S.R., Bartorelli A.L., Trabattoni D., Oemrawsingh P.V., Atsma D.E., Chang M., Marquardt W., Oh J.K., Krucoff M.W., Gibbons R.J., Spears J.R., and AMIHOT Investigators. Acute Myocardial Infarction With Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention. J Am Coll Cardiol 50 (2007) 397-405
3. Walker G. TIMI risk score for UA/NSTEMI. http://www.mdcalc.com/timi-risk-score-for-uanstemi Accessed May 1, 2009
4. Miller T.D., Christian T.F., Hopfenspirger M.R., Hodge D.O., Gersh B.J., and Gibbons R.J. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc-sestamibi imaging predicts subsequent mortality. Circulation 92 (1995) 334-341
5. Gibbons R.J., Miller T.D., and Christian T.F. Infarct size measured by single photon emission computed tomographic imaging with (99m) Tc-sestamibi: a measure of the efficacy of therapy in acute myocardial infarction. Circulation 101 (2000) 101-108
6. Medrano R., Lowry R.W., Young J.B., Weilbaecher D.G., Michael L.H., Afridi I., He Z.-X., Mahmarian J.J., and Verani M.S. Assessment of myocardial viability with 99mTc sestamibi in patients undergoing cardiac transplantation. Circulation 94 (1996) 1010-1017
7. Schomig A., Kastrati A., Dirschinger J., Mehilli J., Schricke U., Pache J., Martinoff S., Neumann F., Schwaiger M., and Stent Versus Thrombolysis for Occluded Coronary Arteries in Patients With Acute Myocardial Infarction Study Investigators. Coronary stenting plus platelet glycoprotein IIb/IIIa blockage compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med 343 (2000) 385-391
8. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. Circulation 329 (1993) 673-682